Daldrup & Söhne Aktiengesellschaft (4DS)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 24.00 |
|---|---|
| 52-week range | 15.10 – 30.10 |
| Return, 1 month / 3 months | +4.3% / +0.4% |
| Return, 1 year / 3 years | +51.2% / +205.8% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 57.9% |
| Worst drawdown (1 year) | -38.4% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Daldrup & Söhne Aktiengesellschaft is a German company that provides drilling services and geothermal energy solutions. It drills wells for geothermal heating and power projects, for water supply and for other subsurface work, serving utilities, municipalities, industry and project developers. The company also offers related services such as well construction, maintenance and geophysical surveying. It is based in Grünwald, near Munich, and carries out projects in Germany and elsewhere in Europe.
On this site Daldrup & Söhne Aktiengesellschaft appears as a stock on the XETRA Stock Exchange (Germany), code 4DS, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Daldrup & Söhne Aktiengesellschaft (4DS) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 24.00 on 23 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 458 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 51.2% and over the last three months it rose 0.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.1% | ||
| From 52-week high | -19.2% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.4% | ||
| 6-month return | 4.3% | ||
| 12-month return, skipping the last month | 44.9% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.4% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 10 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.7% |
|---|---|
| 1 month | +4.3% |
| 3 months | +0.4% |
| 6 months | +4.3% |
| 1 year | +51.2% |
| 3 years | +205.8% |
| 5 years | +420.5% |
Signals
| 50-day / 200-day average | 23.00 / 23.50 |
|---|---|
| Golden / death cross (60 days) | Death, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | EUR 0.1800 |
| 29 Aug 2025 | EUR 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.